---
id: 155
title: Nocardia Species Infections
category: organisms
subcategory: actinomycetes
tags: [Nocardia, TMP-SMX, brain-abscess, pulmonary, immunocompromised]
difficulty: medium
---

## Question

What is the clinical presentation and treatment of *Nocardia* infections? Use the **"Pulmonary + CNS Dissemination in Immunocompromised → TMP-SMX × 6-12 Months"** framework.

## Answer

### ***Nocardia* Species Overview:**

**Organism:**
- **Aerobic actinomycete** (branching, filamentous, Gram-positive, weakly acid-fast)
- **Ubiquitous in soil** (environmental saprophyte)

**Transmission:** Inhalation (pulmonary) or traumatic inoculation (cutaneous)

**Risk Factors:**
- **Immunosuppression:** Transplant (especially lung), chronic steroids (>10mg prednisone daily), biologics (TNF-α inhibitors)
- **Chronic lung disease:** COPD, bronchiectasis
- **HIV (CD4 <250)**
- **Can occur in immunocompetent** (20-30% of cases)

### **Clinical Syndromes:**

**Pulmonary Nocardiosis (Most Common, 70%):**

**Presentation:**
- **Subacute to chronic** pneumonia (weeks to months)
- **Fever, cough, dyspnea, weight loss**
- **Mimics TB or fungal infection**

**Imaging:**
- **Nodules, cavitation, consolidation** (can mimic malignancy)
- **Pleural effusion** (25-50%)
- **Empyema** (can occur)

**CNS Dissemination (30-40% of Pulmonary Cases):**

**Brain Abscess:**
- **Single or multiple** abscesses (ring-enhancing on MRI)
- **Symptoms:** Headache, focal neurologic deficits, seizures, altered mental status
- **HIGH RISK:** Transplant patients, chronic steroids

**Dissemination Route:**
- **Hematogenous** from pulmonary focus (often subclinical lung disease)

**Cutaneous/Lymphocutaneous Nocardiosis:**

**Primary Cutaneous:**
- **Traumatic inoculation** (gardening, farming)
- **Cellulitis, abscess, nodules** (can ulcerate)
- **Sporotrichoid spread** (ascending lymphangitis with nodules along lymphatics)

**Secondary Cutaneous (Disseminated):**
- **From pulmonary source** (rare)

### **Diagnosis:**

**Culture:**
- **Modified acid-fast stain:** Weakly positive (distinguishes from other bacteria)
- **Gram stain:** Gram-positive, branching filaments (resembles fungi, but bacteria)
- **Slow growth:** 3-5 days to weeks on routine media
- **Requires prolonged incubation** (alert lab if *Nocardia* suspected)

**Imaging:**
- **CT chest:** Nodules, cavitation, consolidation (baseline for all pulmonary cases)
- **MRI brain:** ALWAYS obtain in pulmonary nocardiosis (even if asymptomatic) → 30-40% have occult CNS disease

**Speciation:** Important for antimicrobial susceptibility (variable resistance patterns)

### **Treatment:**

**Preferred Agent:**

**TMP-SMX (High-Dose):**
- **TMP-SMX 5 mg/kg (TMP component) IV/PO q8h** (e.g., 2 DS tablets TID for 70kg adult)
- **Most consistently active** against *Nocardia* species

**Alternative Agents (Based on Susceptibility):**
- **Amikacin 15 mg/kg IV daily** (often used in combination for severe disease)
- **Imipenem 500mg IV q6h** OR **meropenem 1g IV q8h**
- **Ceftriaxone 2g IV q12h**
- **Linezolid 600mg IV/PO q12h** (excellent CNS penetration, but resistance can develop)
- **Minocycline 100mg PO BID** (oral option)

**Combination Therapy:**
- **Severe disease or CNS involvement:** TMP-SMX + amikacin (initial 4-6 weeks)
- **OR:** TMP-SMX + imipenem/meropenem
- **Then transition to TMP-SMX monotherapy** after clinical improvement

**Duration:**

| Site | Immunocompetent | Immunocompromised |
|------|-----------------|-------------------|
| **Pulmonary only** | 6 months | 12 months |
| **CNS involvement** | 12 months | 12-18 months |
| **Disseminated** | 12 months | 12-18 months |

**Adjunctive:**
- **CNS abscess:** Consider neurosurgical drainage if large (>2.5 cm) or mass effect

**Monitoring:**
- **TMP-SMX toxicity:** CBC (cytopenias), creatinine (nephrotoxicity), K+ (hyperkalemia)
- **Repeat imaging:** CT chest and brain MRI to assess response

## Key Points

### **ALWAYS Image Brain:**
- **30-40% of pulmonary *Nocardia*** have CNS dissemination (often asymptomatic)
- **MRI brain with contrast** in ALL pulmonary nocardiosis cases

### **Mimics TB/Fungi:**
- **Subacute/chronic pneumonia** with nodules, cavitation
- **Diagnosis requires high suspicion** (alert lab for prolonged incubation)

### **Modified Acid-Fast Positive:**
- **Weakly acid-fast** (partial acid-fast)
- **Distinguishes from other bacteria** (but NOT fungi - fungi are NOT acid-fast)
- **Key diagnostic clue**

### **TMP-SMX = Preferred:**
- **High-dose:** 5 mg/kg (TMP component) q8h
- **Most consistently active** across *Nocardia* species
- **Long duration:** 6-12 months (prevents relapse)

### **Transplant Patients at Highest Risk:**
- **Especially lung transplant** (environmental exposure + immunosuppression)
- **Consider prophylaxis** with TMP-SMX (also covers *Pneumocystis*)

### **Clinical Pearls:**
- **Pulmonary nodules/cavitation in immunocompromised** → consider *Nocardia*
- **ALWAYS image brain** (MRI) in pulmonary cases
- **TMP-SMX 5 mg/kg (TMP) q8h × 6-12 months**
- **Severe/CNS:** TMP-SMX + amikacin (initial), then TMP-SMX alone
- **Modified acid-fast positive, branching Gram-positive rods**
- **Alert lab** (requires prolonged incubation)

## Sources

- [CID: *Nocardia* Infections Guidelines 2024]
- [Transplant ID: *Nocardia* in Solid Organ Transplant 2024]

## Media

N/A
